Logo Image
|Articles|March 1, 2002

Editorial: Asthma, on average

Until we learn to recognize susceptible infants and avert the immunologic response that results in asthma, we must improve the means by which we treat it.

Related Content

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?
Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

View more